NAD+ Protocol: What Exists, and What Does Not

Summary: Research protocols in this field exist, and most of them govern oral precursor trials. The sheet handed over at an infusion clinic is a different object.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

An NAD+ protocol, in the form most people actually encounter, is a printed sheet from an infusion clinic. It lists a course of sessions across a set number of days, a quantity per session, a price for the package, and often a recommendation to repeat the course at intervals.

It looks clinical. It uses clinical vocabulary, it is handed over in a clinical setting by someone in a clinical uniform, and it is called a protocol. Understanding what it is and is not is the single most useful thing a person can do before booking.

What a NAD+ protocol usually turns out to be

That sheet is a service schedule. It describes what the business will sell you and when you should come back. Every element on it was chosen by the provider, and none of it was derived from a study of that schedule.

This is not an accusation of bad faith. A clinic offering infusions has to decide how many sessions to sell, how long each takes and how far apart they sit. Somebody had to write something down. The decision was made in the ordinary way businesses make operational decisions, informed by what other clinics do and by what customers will book. Every NAD+ protocol of this kind was written that way.

The trouble is only that the resulting document is presented in the register of medicine, and readers apply the assumptions that register carries: that someone reviewed it, that it reflects evidence, that a body of expertise stands behind the specific numbers on the page. For a service schedule none of those assumptions holds.

A real protocol exists, and it governs something else

There are genuine research protocols in this field. Interventional studies of NAD biology have been run in humans, filed in advance, reviewed by ethics committees, and carried out by named investigators.

The overwhelming majority of them studied oral precursors, nicotinamide riboside or nicotinamide mononucleotide, taken as capsules and converted inside the body. Those protocols are real documents describing real human research, and they do not describe an infusion clinic's course of intravenous NAD+.

So the position is unusual. Unlike most compounds covered on this site, protocols in this area are not absent. They are present, rigorous, and about a different intervention delivered by a different route. Citing their existence to lend weight to an NAD+ protocol sold as a course of infusions is a substitution, and it works because both things are called NAD research.

What each document obliges its author to do

Compare the last column down the rows. That is the actual subject of this article, and the quantities on any of these sheets are a distraction from it.

The consecutive day course, and where it came from

The most recognisable feature of these packages is the run of sessions on consecutive or near consecutive days, followed by a maintenance schedule.

Ask where that shape came from and the trail does not lead to a study of that shape. It leads to other clinics offering something similar, and behind them to practices that spread through the industry as it grew. A structure that everyone uses feels like a standard. A standard implies somebody set it, and in this case nobody with an evidential obligation did.

There is a simple test for any schedule presented as clinical. Could its author tell you what would make them change it? A research protocol has that answer written into it in advance: specific findings trigger specific responses, including stopping. A label has it as warnings and monitoring requirements. A service schedule generally has no such content, because it was not built to answer that question.

Bundling makes the whole thing unreadable

Many clinics sell infusions in combinations, adding vitamins, minerals, amino acids or antiemetics to the same bag or the same appointment.

Commercially this is sensible. Evidentially it is ruinous. If several substances arrive at once, no report afterwards can attribute anything to any one of them. A person who feels better cannot say which component did it, and neither can the clinic, and neither can anyone reading the testimonial later.

This compounds the setting effect that any infusion appointment carries. An hour of rest, attention from staff, a paid intervention and an expectation of benefit are all present before a single active ingredient is considered. Separating a molecule from that package is what a blinded trial is for, and a bundled clinic session is the furthest thing from one.

The home version of the same document

Away from clinics, an NAD+ protocol is something thinner still: a suggested use line on a vendor page, or a schedule pasted into a forum thread by someone describing what they do.

Everything said above applies, minus the parts of a clinic that offer some protection. There is no trained person watching, no controlled environment, no equipment for a reaction, and no record that you received anything at all. The buyer reconstitutes a powder themselves, which introduces its own set of unknowns about sterility and concentration, and then follows instructions written by the party who profited from the sale.

The vial itself deserves a sentence, because a protocol assumes a known substance and this is where that assumption fails hardest. Material sold as a research chemical carries no identity testing you can inspect, no independent assay of concentration, and no sterility guarantee. A certificate supplied by the seller is a document the seller controls. Even a perfect schedule, followed exactly, is a schedule for administering something whose contents are unverified, and no amount of care about timing compensates for that.

There is a specific asymmetry worth naming here. The parts of these documents that are easy to copy are the numbers and the calendar. The parts that make a real protocol protective are screening, supervision, verified material and a rule for stopping, and none of those copies at all. So the copying process systematically strips out the protection and preserves the instruction, which is the worst possible filter and the one that operates by default.

A reader who notices only this from the article has taken the useful part. What travels between a research protocol and a forum post is never the thing that made the protocol worth trusting.

Reading a sheet you have already been handed

Four questions do most of the work, and none of them requires any technical knowledge.

Who wrote this, and what were they responsible for? Which intervention does the evidence they cite actually concern, an oral precursor or intravenous NAD+? Who is excluded, and how would they know whether that includes me? What would make them tell me to stop, and what happens then?

A document that answers all four is doing something clinical. A document that answers none is a price list with medical typography. Most sheets in this category sit closer to the second, and noticing that is not cynicism. It is reading the document for what it is rather than for what its formatting suggests.

The objections this gets

Does an NAD+ protocol from a real medical clinic count as clinical?

The setting does not confer authority on the schedule. A clinic can be staffed by qualified people, be perfectly clean and behave responsibly, and its infusion course still has no approved label behind it, because none exists for injected NAD+ in any market.

Precursor trials are real research. Why not use their protocols?

Because they describe capsules taken by mouth and converted in the body. Route changes the exposure, and an intravenous course is a different intervention. A protocol is specific to what it studied, which is the whole reason protocols are written down.

Is a consent form the same as screening?

No. Consent records that you were told about risks and agreed to proceed. Screening is an active process of deciding whether you should receive something at all, based on stated exclusion criteria. The two are often confused because both involve signing.

What if my clinic monitors me during the session?

Watching for an immediate reaction during an appointment is worth having and is not the same as the monitoring a trial performs, which follows defined measures over time and feeds into decisions about continuing. Both are called monitoring, and they answer different questions.

Should I tell my own doctor about a course I have booked?

Yes. They cannot consult a label that does not exist, but they know your medications and your history, and they are the person who would have to interpret anything unexpected afterwards. That is worth more than the sheet.